Spriasollc.com

Spriasollc.com has Server used 50.62.160.147 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2013-08-09 (6 years, 330 days) and hosted in Scottsdale United States, server ping response time 77 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Spriasollc keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Spriaso llc

Hosting Provider

Website: Spriasollc.com
Hostname: p3nwvpweb117.shr.prod.phx3.secureserver.net
Country:
Region: AZ
City: Scottsdale
Postal Code: 85260
Latitude: 33.61190032959
Longitude: -111.89060211182
Area Code: 480
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Bigdoggis.net (0 seconds ago)

   » Bhhsnwrealtyassociates.com (0 seconds ago)

   » Jeff-z.com (16 seconds ago)

   » Koreahapkidofederation.net (13 seconds ago)

   » Asuitesalon.com (41 seconds ago)

   » Newdeal20.org (12 seconds ago)

   » Amwaste.com (6 seconds ago)

   » Bojaxshooting.com (4 seconds ago)

   » Aimglobal.org (9 seconds ago)

   » Tdsltd.com (7 seconds ago)

Results For Websites Listing

Found 43 Websites with content related to this domain, It is result after search with search engine

Spriaso LLC

(5 day ago) Spriaso is a biopharmaceutical company dedicated to improving therapeutics through innovative patient friendly product options.

http://spriasollc.com/

DA: 14 PA: 14 MOZ Rank: 15

Spriaso Competitors, Revenue and Employees - Owler Company

(15 day ago) Spriaso is a Private company. Spriaso has an estimated revenue of <$1M and an estimate of less <10 employees.

https://www.owler.com/company/spriasollc

DA: 13 PA: 19 MOZ Rank: 32

Spriaso | Crunchbase

(21 day ago) Spriaso is a biopharmaceutical company. Try Pro free Solutions

https://www.crunchbase.com/organization/spriaso

DA: 18 PA: 21 MOZ Rank: 39

Spriaso Announces Approval Of New Drug Application For The

(1 month ago) SALT LAKE CITY, July 1, 2015 (GLOBE NEWSWIRE) -- Spriaso LLC. (www.spriasollc.com), today announced FDA approval of a New Drug Application (NDA) for Tuxarin ER ®, a unique high strength long acting Rx cough/cold combination product containing codeine and chlorpheniramine.Tuxarin ER ®, co-developed with Nexgen Pharma, will be the first product to offer long lasting cough suppression with a

https://www.biospace.com/article/releases/-b-spriaso-b-announces-approval-of-new-drug-application-for-the-long-acting-codeine-antitussive-with-a-popular-anti-histamine-/

DA: 16 PA: 50 MOZ Rank: 50

Spriaso Announces Filing Of New Drug Application For The

(1 month ago) SALT LAKE CITY, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Spriaso LLC. (www.spriasollc.com), today announced FDA acceptance of a New Drug Application (NDA) to seek approval for Rinotuss12®, a unique Rx cough/cold combination product containing codeine and chlorpheniramine.Rinotuss12®, co-developed with Nexgen Pharma, will be the first product to offer long lasting cough suppression with a safer

https://www.biospace.com/article/releases/-b-spriaso-b-announces-filing-of-new-drug-application-for-the-first-long-acting-codeine-antitussive-with-a-popular-antihistamine-/

DA: 16 PA: 50 MOZ Rank: 50

Spriaso Announces Approval of New Drug Application for the

(3 day ago) SALT LAKE CITY, July 1, 2015 (GLOBE NEWSWIRE) -- Spriaso LLC. (www.spriasollc.com), today announced FDA approval of a New Drug Application (NDA) for Tuxarin ER ®, a unique high strength long

https://www.globenewswire.com/news-release/2015/07/01/749018/10140262/en/Spriaso-Announces-Approval-of-New-Drug-Application-for-the-Long-Acting-Codeine-Antitussive-With-a-Popular-Anti-Histamine.html

DA: 21 PA: 50 MOZ Rank: 50

Spriaso Announces Approval of New Drug Application for the

(28 day ago) — Spriaso LLC. (www.spriasollc.com), today announced FDA approval of a New Drug Application (NDA) for Tuxarin ER(R), a unique high strength long acting Rx cough/cold combination product containing codeine and chlorpheniramine. Tuxarin ER(R), co-developed with Nexgen Pharma, will be the first product to offer long lasting cough suppression

https://pharmachitchat.wordpress.com/2015/07/02/spriaso-announces-approval-of-new-drug-application-for-the-long-acting-codeine-antitussive-with-a-popular-anti-histamine/

DA: 28 PA: 50 MOZ Rank: 50

Spriaso Announces Filing of New Drug Application for the

(12 day ago) (www.spriasollc.com), today announced FDA acceptance of a New Drug Application (NDA) to seek approval for Rinotuss12®, a unique Rx cough/cold combination product containing codeine and

https://www.globenewswire.com/news-release/2014/11/06/680490/10106692/en/Spriaso-Announces-Filing-of-New-Drug-Application-for-the-First-Long-Acting-Codeine-Antitussive-With-a-Popular-Antihistamine.html

DA: 21 PA: 50 MOZ Rank: 50

Gordhan Patel - Business Profile | American Standard

(2 month ago) View Gordhan Patel's business profile as Chairman and Founder at American Standard Circuits Inc. Find contact's direct phone number, email address, work history, and more.

https://www.zoominfo.com/p/Gordhan-Patel/99231453

DA: 16 PA: 25 MOZ Rank: 41

Recently Analyzed Sites